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Summary
Macrophage stimulating protein (MSP) was purified to homogeneity from human blood plasma
by selection ofbiologically active fractions obtained by sequential immunoaffinity and high pressure
liquid ion exchange chromatography. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis
the molecular mass of MSP was 70 kilodaltons (kD); under reducing conditions two gel bands
were seen, at 47 and 22 kD. The disulfide-linked two-chain structure of MSP was confirmed
by separation of reduced and alkylated MSP chains. A computer search comparison of six partial
sequences ofMSP digests showed that MSP has not been recorded in data banksofprotein sequences.
Two MSP fragments had >80% identity in overlaps of 12-16 residues to sequences in the protein
family that includes human prothrombin, plasminogen, and hepatocyte growth factor. The
concentration of purified MSP required for half-maximal biological activity was the order of
10 -1° M. In addition to making mouse resident peritoneal macrophages responsive to chemo-
attractants, MSP caused the appearance of long cytoplasmic processes and pinocytic vesicles in
freshly plated macrophages. MSP also caused phagocytosis via the C3b receptor, CR1. Whereas
resident peritoneal macrophages bind but do not ingest sheep erythrocytes opsonized with IgM
anti-Forssman antibody and mouse Cab, addition of MSP caused ingestion. Thus, MSP causes
direct or indirect activation of two receptors of the mouse resident peritoneal macrophage, CR1
and the C5a receptor.
T
he inflammatory or cytotoxic activity of leukocytes
is subject to complex regulation. A well-studied example
is the mouse peritoneal macrophage, for which distinctions
have been made between resident, inflammatory, and immuno-
logically activated populations. Generation of a macrophage
capable of tumor killing requires a priming signal that acts
on an inflammatory macrophage, but not on a resident mac-
rophage; this creates a transient state during which contact
with the target cell initiates the cytotoxic response (1). Other
examples abound, including neutrophil priming that increases
the magnitude of an agonist-induced metabolic burst (2).
We found that a stimulating signal was required for resi-
dent peritoneal macrophages from C3H mice to make a
chemotactic response to C5a. Macrophages in RPMI-1640
medium did not migrate to C5a unless serum was added to
the cell suspension (3) . The stimulating effect of serum was
concentration dependent, over a range of about 2 to 12%
heat-inactivated serum. Sera from different mammals, in-
cluding mice and humans, were effective. Fractionation of
human serum for the stimulating effect led to partial
purification of a protein (4), which we called macrophage
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stimulating protein (MSP)1. In addition to making resident
macrophages responsive to C5a, MSP induced morpholog-
ical changes within 1 h after macrophages were plated in tissue
culture dishes: the cellsassumed elongated shapes, with long
processes, and increased numbers of vacuoles were evident.
The low concentration of MSP in serum precluded com-
plete purification by conventional techniques. We have now
achieved this byacombination ofimmunoaffinity and HPLC
chromatography. Screening of partial sequences of MSP in
the protein data bank (5) shows that MSP is a new entry
on the list of described proteins.
Materials and Methods
MSPBioassay.
￿
The assayforMSP is basedon aconcentration-
dependentincrease in thechemotactic response of resident perito-
1 Abbreviations used in this paper. DTT, dithiothreitol; EIgMC3b, sheep
erythrocytes opsonizedwith IgManti-Forssman antibody andmouseC3b;
HGF, hepatocyte growth factor; MSP, macrophage stimulating protein;
VBS, veronal buffered saline.
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1227-1234nealC3H mouse macrophages to endotoxin-activated mouseserum
(3). Macrophages obtained by peritoneal lavage with 7-8 ml of
RPMI 1640 medium containing2% BSAwere centrifuged at 4°C
for 10 min at 2508 and resuspended in RPMI 1640 without added
protein at a cell concentration of 106/ml . Bottom wells of amul-
tiwell chemotaxis chamber (6) were filled with chemoattractant
(a 1/200 dilution of endotoxin activated mouseserum [7]) and cov-
ered with a 10-dim thick polyvinylpyrrolidone-coated polycarbonate
membrane with 5-1.m holes. After gasket and top plate were added
to complete assembly ofthe chamber, upper wells were filled with
50,ul volumes ofmacrophage suspensions in RPMI 1640 medium
containing the stimulating protein to be assayed . During the incu-
bation period of 3 h at 37°C in humidified air with 5% COz,
macrophages migrated through holes in themembrane andremained
attached to the attractant side of themembrane . The chamberwas
then disassembled, andcells were wipedaway from the nonmigrated
side of the membrane. After air drying and staining with Difl-
Quik (American Scientific Products, McGaw Park, IL), migrated
cells were counted with an image analyzer (8) . MSP fractions were
assayed in duplicate, and results were expressed as the percentage
ofinput macrophages that migrated .Aunit ofMSPperml of test
solution was defined as the reciprocal of the dilution required to
induce -30% of the maximal chemotactic response obtained at
the plateau of the dose-response curve.
Isolation of MSP Antigen for Monoclonal Antibody Production .
Purification ofMSPfrom 3,600ml ofoutdated frozen plasma (Blood
Bank, Clinical Center, National Institutes ofHealth, Bethesda, MD)
was based in part on published methods (4) . Plasma was lyophi-
lized and reconstituted to 1/3 of the starting volume. 8 g of
Na2SO4 per 100 ml of concentrated plasma at 20°C were added
to precipitate unwanted high mol wt proteins . Gel filtration of the
supernatant on Sephadex G-200 (Pharmacia LKB, Piscataway, NJ)
yielded fractions with MSP activity in a region corresponding to
a molecular mass of -100kD. MSPwas further purified by DEAE-
cellulose chromatography, flat bed isoelectric focusing, another
G-200 gel filtration, and equilibrationwith formalin-fixed Cowan
strain Staphylococcus aureus (Zymed Laboratories, San Francisco, CA)
to remove traces of IgG .
Immunization of Mice and Production of Monoclonal Anti-MSP .
MSP, partially purified as described above and emulsified in CFA,
was injected intraperitoneally into BALB/c mice . The amount of
protein per injection was 280 fig. MSP in incomplete Freund's ad-
juvant was injected subcutaneously 2wk later. The followingweek,
serum from the mice was tested for anti-MSP activity by applica-
tion to aminicolumn of Protein-A Sepharoseand measurement of
the capacity of the washed column to absorb applied MSP (9). 2
wk after this, 0.1 ml ofMSP solution was injected intravenously;
spleens of the two mice with the most anti-MSP serum activity
were removed 4 d later. Fusion, cloning, and propagation of cell
hybrids were done by published methods (10) . Spleen cells were
fused at a 5:1 ratio with NS-1 cells (11) . Beginning at about 10
d, supernatants from the hybridcellswere tested by theimmunoab-
sorbance assay (9) for anti-MSP activity. Cells from positive wells
were cloned. Clones that produced IgG anti-MSP were passed in-
traperitoneally in mice, and IgGwas purified from ascitic fluid on
Protein-A Sepharose.
Purification of MSP by Immunoaffmity and HPLC Chromatog-
raphy . Four 6 liter batches of outdated human plasma were used
for large scale purification ofMSP . A batch was thawed, filtered
through sterile gauze, centrifuged at 20°C for 15 min at 10,000
rpm in aJA-10 rotor in a centrifuge (J2-21 ; Beckman Instruments,
Fullerton, CA), filtered again through gauze to remove floating
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lipid, and finally filtered through a glass fiber prefilter (Nalgene
280-5000 ; NalgeCo., Rochester, NY).Theimmunoaffinity column
for the first purification step had a diameter of2.5 cm and a bed
height of 8 cm. It was packed with CNBr-Sepharose (Pharmacia
LKB) that hadbeen mixedwith 240 mg of IgG monoclonal anti-
MSP Plasma wasrunthrough thecolumn with a hydrostatic head
of about 3 m, over a period of 4 h at 20°C. After thecolumn was
rinsed with 0.15 M NaCl, 0.5M Tris buffer, pH 8.0, MSP was
eluted with 0.1 M, pH 2.5 glycine buffer. Fractions of 5 ml were
collected into tubes containing 1 ml of 0.5 M, pH 7.9, potassium
phosphate buffer. The Am peak, comprising about 110 ml, was
dialyzed at 4°C overnight against 0.03 M NaCl, 0.02 M 3-[N-
morpholino]propanesulfonic acid, pH 6.7, whichwasthe starting
buffer for CM-HPLC. It wascentrifuged at 20,000 rpm in a Type
30 rotor of an ultracentrifuge (L8-70 ; Beckman Instruments) at
5°C, concentrated on an Amicon (Amicon Corp ., Danvers, MA)
YM-10 ultrafilter to 2 ml, dialyzed again against starting buffer,
and filtered through a 5 ml,0.45jimCentrex unit (Schleicher and
Schuell, Inc., Keene, NH). It was then applied through a 2-ml
sample loop to a Beckman Spherogel-TSK CM-3SW dp 10 ktm
column (7.5 mm x 7.5 cm). Running conditions were flow of
1 ml/min, 2 min/fraction, AZ8o absorbance range of 1.28 . After
the flow-through, a linear gradient ofNaCl in starting buffer was
run to a limit concentration of 0.3M. Fractions were assayed for
MSP biological activity. We pooled and froze about 10 fractions
across theMSPpeak (HPLC-CM-1 MSP) . After threemore batches
of plasma were processed, the fourHPLC-CM-1 MSP peaks were
pooled, dialyzed against HPLC-CM starting buffer, concentrated
to 2 ml, dialyzed against starting buffer again, filtered, and chro-
matographed on the HPLC-CM column under the same condi-
tions as the first run except for an A28o absorbance range on the
chart recorder of 0.64 . Fractions across the A,w peak were pooled
(HPLC-CM-2 MSP).
GelElectrophoresis.
￿
SDS-PAGE ofMSPpurified by immunoab-
sorption and HPLC-CMwas in aPharmacia Phastgel system (Phar-
maciaLKB) with a 10-15% gradient gelunderboth reducing and
nonreducing conditions .
Reduction and Alkylation of MSP .
￿
4 ml of purified MSP
(HPLC-CM-2 MSP) were dialyzed against 10 mM NH4HCO3 ,
lyophilized and dissolved in 200 ail water. From amino acid anal-
ysis ofa 5 Pl sample of this material, there were 2nmol or approxi-
mately 215,ug of totalMSPWe lyophilized 180 Al andreconstituted
the MSP in 25 P .1 of 6 M guanidine HCI, 0.5 M Tris HCI, pH
8.2 . Approximately6.5 p,mol ofdithiothreitol (DTT) in avolume
of 50 iil of the guanidine-tris diluent was added. After a 4-h
equilibration at 20°C, 19 pmol of iodoacetamide in a volume of
36 ul was added, and the solution was held at 20°C in the dark
for 20 min.Thereducedand alkylatedMSPheavyand light chains
were separated on a Superose 12 FPLC column (Pharmacia LKB)
that was equilibrated with 6M guanidineHCI, 0.05MTris HCI,
pH 7.8 .Theconcentration ofguanidineHCIin the heavyand light
chain pool fractions was reducedby ultrafiltration on aCentricon
10 filter and refiltered after addition of Tris buffer. Each sample
was then dialyzed against 0.1% acetic acid, lyophilized, andrecon-
stituted in 200P.1 of1% acetic acid. Aliquots were used foramino
acid analysis and SDS-PAGE .
Reduction and Pyridylethylation ofMSP .
￿
A 4.5 nmol sample o£
HPLC-CM-2 MSP in 300 iil of 0.5 M Tris-HCI, pH 8.2, con-
taining 6M guanidine hydrochloride and20% 2-propanol was re-
ducedby addition of 100wg DTT After 4hat room temperature,
it was alkylated by addition of 30 1il of 10% 4-vinylpyridine in
2-propanol . After 3 h, pyridylethylated MSP was applied to a Su-perose 12 column in pH 8.0, 0.05 M Tris-HCI containing 6M
guanidine hydrochloride. Separated heavy and light chain peakswere
dialyzed against 0.1% acetic acid and then lyophilized .
Sequencing of Endopeptidase-Digested Pyridylethylated Heavy and
Light Chains. The lyophilized pyridylethylated heavy and light
chains were dissolved in 501 .11 of 0.1 Mammonium bicarbonate,
pH 9.5, containing 4M urea . The chains were digested at 35°C
by addition of 0.2 lag lysylendopeptidase, followed by another 0.2
Ag after 8 h, for a total incubation time of 24 h . The digests were
separated on an 0.21 x 3 cm BU-300 reverse phase column
(Thomson Instrument Co., Springfield, VA) . The larger, well-
separated peakswere sequencedby N-terminal Edman degradation
on an Applied Biosystems (Foster City, CA)470Apeptide sequencer
equipped with an on-line 120A phenylthiohydantoin analyzer.
Measurement ofEIgMC3b Binding and Phagocytosis by Resident
Mouse Peritoneal Macrophages. Reagents included sheep blood, an-
ticoagulated with acid-citrate-dextrose; veronal buffered saline with
0.1% gelatin (VBS-gel) : 0.14M NaCl, 0.1 mM veronal, pH 7.4,
1 mM MgC12, 0.15MM CaC12 ; rabbit IgM anti-Forssman anti-
body, kindly supplied by Dr. Tibor Borsos (Dept . of Pathology,
Uniformed ServiceU . Health Science, Bethesda, MD); C5-deficient
AKR mouse serum, stored at -80°C; DMEM; and ammonium
chloride lysis buffer (0.16M NH4C1, 0.01 MKHC03, 0.001 M
EDTA, pH 7.4) . Sheep erythrocytes opsonized with IgM anti-
Forssman antibody and mouse Cab (EIgMC3b) were prepared as
follows : sheep E were washed twice with VBS-gel and suspended
to a concentration of 2 x 108 E/ml . To 1 ml E were added 0.1
ml IgM anti-Forssman antibody. After 45' at 37°C, the cells were
washed andresuspended in 10 ml VBS-gel + 0.6 mlAKRmouse
serum . After 20' at 37°C, the cellswere washed 3x in cold VBS-
gel and then stored at VC in 4 ml VBS-gel.
For phagocytosis experiments, 0.5 ml aliquots of mouse resi-
dent peritoneal cells at a concentration of 8 x 10 5 cells/ml
DMEM withoutFCS (obtained as described for theMSPbioassay)
were added to 24-well polystyrene plates (Costar, Cambridge,MA).
Macrophages comprisedabout 70% of total peritoneal cells . After
1 h at 37°C, the plates were washed twice withDMEM, and then
0.5 mlEIgMC3bwere added, followed by 0.1 ml ofDMEM with
different concentrations ofMSP The ratio oferythrocytes to peri-
toneal cells was50:1. After incubation for specified intervals, nonad-
herent EIgMC3b were washed out of the wells, and 0.5-ml ali-
quots ofammonium chloride lysis buffer were added . This buffer
wasremoved after 2.5 min, and the monolayers were stained with
DiffQuik . Thebottoms ofthe wellswere then cut outandmounted
on glass slides so that cells could be examined with a 100x oil
immersion objective.
Results
Purification ofMSPby Immunoainity andCM-HPLCChro-
matography. MSPwas partially purified by passageofhuman
plasma down aSepharose monoclonal anti-MSP column . No
MSPbiological activity was foundin thepass-through volume.
After thecolumn was washed withPBS to remove unbound
protein, MSP was eluted with, pH 2.5, glycine buffer. This
single step achieved an approximately 5,000-fold purification
(Table 1) . However, since the preparation showed a large
number ofbands in SDS-PAGE gels stainedwith Coomassie
blue, MSP was further purified by CM-HPLC. As shown
in the upper panel of Fig. 1, most of the macrophage
stimulating activity coeluted with a well-defined Also peak.
Thiswas the last major proteinpeak to be eluted by theNaCl
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" Azw
# Frozen aliquots from each fractionation step were thawed and assayed
with a single preparation of mouse peritoneal macrophages . A unit of
MSP/ml test solution is defined as the reciprocal of the dilution required
to induce - 30% of the maximal bioassay response. Based on a Mr of
70 W, 30% of the maximal bioassay response for HPLC-CM-2 MSP
occurs at 6 x 10-11 M.
gradient, which reflects the fact that during fractionation the
isoelectric point ofMSP shifts upward to a value that is high
relative to most serum proteins (12) . Thesmall peak of bio-
logical activity that eluted earlier may representMSP with
a pl intermediate between the native value of 5.8 and the
pl in 6Murea of 7.6 (12) . To minimize contaminating pro-
tein, theMSPpeak was rechromatographed, as shownin the
lower panel of Fig . 1. Asummary of MSP purification and
yield is shown in Table 1 . Most of the starting plasma pro-
tein wasremoved in the immunoaffinity column step. How-
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Figure 1.
￿
HPLC-CM purification of MSP . (Upper panel] chromatog-
raphy of MSP eluted from immunoaffinity column . See Materials and
Methods for running conditions. (") MSP activity of fractions . (Lower
panel) rerun of MSP peak .
Table 1 . Purification ofMSP
Protein" MSP/protein# Total MSP
mg U/mg U
5 liters human plasma 35 x 10 4 6 2 x 106
Anti-MSP column eluate 67 3 x 10 3 2 x 105
HPLC-CM-1 eluate 1.5 7 x 10 4 10,
HPLC-CM-2 eluate 0.6 2 x 10 5 10 5Figure 2.
￿
SDS-PAGE ofpurified HPLC-CM-2MSPunder nonreducing
(lanes A, B, andC and reducing (lanes D, E, and F) conditions. The
amounts applied per lane were 125, 250, and 500 ng, respectively, for lanes
A, B, and C and D, E, and F.
ever, as indicated by Fig . 1 and by the data in the table, MSP
was only about 1% ofthe total anti-MSPcolumn eluate pro-
tein . A 100-fold increase in specific activity was achieved by
the two sequential HPLC-CM runs .
Polyacrylamide Gel Electrophoresis ofMSP .
￿
SDS-PAGE of
purified MSP on a 10-15% polyacrylamide gradient gel, fol-
lowed by staining with Coomassie blue, showed a single band
" Based on estimated molecular masses from SDS-PAGE of 70, 47, and
22 kD for native MSP, a chain and A chain .
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￿
Separation on Superose 12 of reduced and alkylated MSPa
and j3 chains in the presence of6Mguanidine hydrochloride. See Materials
and Methods for details.
under nonreducing conditions and two bands under reducing
conditions (Fig. 2) . This indicated thatMSP comprised two
disulfide-linked chains (ot and S) . By comparison with Mr
markers, estimates for native MSP, a chain and )3 chain were
70, 47, and 22M respectively. From the specific activity
of HPLC-CM-2 MSP (Table 1) and an approximate molec-
ular mass of 70M we estimated that the concentration of
pure MSP required for a half-maximal response in the bio-
assay is the order of 10 -1 ° M .
Amino Acid Composition and Partial Sequence Data for
MSP . The first column of Table 2 shows the amino acid
composition of native MSP, based on a molecular mass of
70W. After reduction and alkylation of MSP,a anda chains
were separated on Superose 12, as shown in Fig. 3 . Amino
acid composition data for a and a chains are shown in the
second and third columns of Table 2 . The sums for a and
(3 chains show reasonable agreement, for the most part, with
values for native MSP.
A partial NH2-terminal sequence of reduced and alkylated
a chain was obtained, but NH2-terminal blockage of the a
chain precluded sequencing. Therefore the chains were digested
with lysylendopeptidase and separated into a series of well-
resolved peaks by reverse phase chromatography. Partial se-
quences offive fragments from each of the chains were deter-
mined (Fig. 4) . The longest sequences comprised 23 residues .
The sequence of one of the (3 chain fragments was identical
to that of the undigested (3 chain N-terminus. Additional
sequence information was obtained fromMSP that was cleaved
with cyanogen bromide . The six sequences with the fewest
ambiguities (indicatedby asterisks in Fig. 4) were compared
with sequences in the protein data bank (5) . Two of the six
fragments had highly significant sequence similarities to
members of a protein family that include prothrombin, plas-
minogen, and hepatocyte growth factor (HGF) . Like MSP,
these three proteins have a and a chains . The a chain frag-
ment BU-12 had 81% identity in a 16 residue overlap with
residues 348-363 of human HGF and 92% identity with
residues 152-164 of bovine prothrombin. The BU-11 frag-
Table 2. Amino
Amino Acid
Acid Composition
Native MSP
ofMSP
Residues/mole"
a Chain 0 Chain
D 45 35 12
E 65 39 24
S 33 21 16
G 117 78 54
H 17 12 4
R 33 26 9
T 41 26 10
A 59 40 17
P 64 40 14
Y 11 11 4
V 52 25 16
M 8 4 3
1 13 7 6
L 47 26 15
F 18 14 5
K 22 16 7
Total 645 420 216MSP, cleaved by CNBr
5
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CB-5 : PLTGYEV-LGTLFQNPQ-GE[S]L
a-CHAIN, lysylendopeptidase digest
*BU-7 : G EGY[E]GT A-TTTAG- P[E]Q E-DAQ-
BU-8 : F N - E A A G V E V N N A E Y -
S YVD
￿
GE
*BU-11 : FLDQGLDD NYCRNP0 GSE-
W
*BU-12 : DLRE NF-RNPD G[S]EAP-
BU-14 : GVQ-QR[W]SAET[P]---QF-
-CHAIN, lysylendopeptidase digest
*BU-5 : C E IAGWGETK
*BU-9 : VVGGHPGN[S]PW[T]V-L-NNQ-
BU-12 : FLPAGP0DN-[C]RNPDGQ-
DQAL
BU-13 : DL-ENF--NPDG[S]E--
*BU-16 : LERSVTLNQRVAL ICLPPE[E]YV[V]-
-CHAIN, alkylated
VVGG-PGNSP-[T]V[S]LRNR-
Figure 4 .
￿
Partial amino acid sequences ofMSP . Sequences with asterisks
(') were compared in theprotein databank . Identity ofresidues inbrackets
([l) was uncertain because of low yield. Dashes (-) represent undeter-
mined residues . Amino acid letter codes in the second rowof a sequence
indicate a contaminating fragment in the purified material . The under-
lined sequence in a chain fragments BU-11 and BU-12 is a highly con-
served kringle motif (see Discussion).
ment of the ca chain had 83% identity with human plas-
minogenresidues 505-516. The residues of the three related
proteins with similarity to the MSP ci chain fragments are
all located in thea chains of these proteins . The 10-residue
,3 chainfragment BU-5 corresponded, with three mismatches,
to 0 chain residues 689-698 of human plasminogen .
Effects ofMSP on Mouse Resident Peritoneal Macrophages.
￿
As
noted in the Introduction, a stimulating signal was required
for resident peritoneal macrophages from C3H mice to make
a chemotactic response to C5a. The signal was present in
mammalian serum, and a bioassay based on the stimulating
effect was used forMSP purification. Fig . 5 shows this effect
as a function oftheconcentration ofpureMSP in the macro-
phage cell suspension . Whereas macrophages inRPMI 1640
did not migrate to C5a, the addition of MSP made them
responsive . The EC5o was ti5 x 10 -11 M MSP .
The effect ofMSP on resident peritoneal macrophage re-
sponsiveness to C5aledus to explore anotherreceptor-mediated
motility event that also requires an activating signal . Although
EIgMC3b bind avidly to the Cab receptor (CR1) ofmono-
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Figure 5.
￿
Effect ofMSPon the chemotactic response ofmouse resident
peritoneal macrophages to C5a . Results are expressed as the percentage
of input macrophages that migrated to the attractant side of the polycar-
bonate membrane. Error bars are SEM's for triplicate cell counts of 1 mm2
of membrane. Migration in the absence ofMSP was 2%. The EC50 in
this experiment was 3 x 10-10M.
cytes or resident peritoneal macrophages, binding is not fol-
lowed by phagocytosis unless an additional signal (aT cell
lymphokine (13),PMA (14), fibronectin (15), serumamyloid
P (15), or laminin (16)) is provided, or unless cells are acti-
vated in vivo by induction of a peritoneal exudate (17) . Table
3 confirms that mouse resident peritoneal macrophages do
not ingest EIgMC3b (17), and shows that MSP stimulated
ingestion . Whereas not more than 2% of resident macro-
Table 3.
￿
MSP Stimulation of Ingestion ofEIgMC3b
To monolayers of mouse resident peritoneal macrophages were added
EIgMC3b, with or without 10-9 M MSP. After the indicated times
at 37° C, nonadherent erythrocytes were washed away ; phase microsco-
py showed massive rosetting oferythrocytes to all macrophage monolayers.
Adherent erythrocytes were then lysed, and monolayers were stained with
Dig-Quick. Erythrocytes within macrophages survived the lysis buffer.
Monolayers were examined with a 100x oil immersion objective for the
percentage of macrophages with at least one ingested erythrocyte ; the
mean ± theSEM ofthree 100-cell counts was calculated for each monolay-
er . Results are shown for two experiments .
Min. of incubation
Percentage
ingested
0 MSP
of cells with
EIgMC3b
10- e M MSP
30 2±0.3 52±3
60 1±0.3 60±2
90 1±0.3 60±4
30 1±0.3 48±4
60 2±0.3 48±4
60 2±0.3 63±5
90 2±0.6 54±2100
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Figure 6 .
￿
Effect of different concentrations of MSP on phagocytosis of
EIgMC3 by mouse resident peritoneal macrophages. To macrophage
monolayers were added EIgMC3, with or without MSP. After 1 h at
30°C, nonadherent erythrocytes were washed away; phase microscopy
showed massive rosetting of erythrocytes to all macrophage monolayers.
Adherent erythrocytes were then lysed, and monolayers were stainedwith
DiffQuik . Monolayers were examined with a 100 x oil immersion objec-
tive for the percentage ofmacrophages with at least one ingested erythro-
cyte ; the mean ofthree 100-cell counts was calculated for each monolayer.
Results are shown for three experiments .
phages adherent to polystyrene tissue culture plastic ingested
bound EIgMC3b, addition of MSP with the erythrocytes
caused 50-60% of the macrophages to ingest EIgMC3b.
Phagocytosis was rapid ; no significant increase in the per-
centage of phagocytic macrophages was found after 30 min .
Fig . 6 shows the percentage of macrophages with ingested
erythrocytes as a function of MSP concentration . The peak
percentage of phagocytic macrophages ranged from 64% to
93% in the three experiments, and the mean ECSo was 3 x
10 -11 M .
Discussion
Screening ofMSP ot and a chain partial sequence data in
the protein data bank (5) shows that MSP is a newly described
protein . The sequence similarities to portions ofhuman pro-
thrombin, plasminogen, and HGF are ofgreat interest . Pro-
thrombin, plasminogen, and the precursor form ofHGF (18)
are all single chain proteins which can be activated by cleavage
at one site to form ci and # chains . For example, conversion
ofplasminogen to active plasmin occurs when a single Arg-
Val bond is cleaved, resulting in a two chain structure held
together by a disulfide bond (19) . In addition to their sequence
similarities, common features ofMSP, HGF, and plasmin in-
clude comparable Mr of the ci and (3 chains, linkage of these
chains by a single disulfide bond, and a valine residue at the
N-terminus of eachachain . Another structural motif shared
by plasmin, HGF, and prothrombin is a series of oi chain
triple disulfide loops, called kringles. The kringle repeats twice
in prothrombin, four times in HGF and five times in plas-
minogen . The sequence NYCRNPD, which forms the base
of one of the disulfide loops, is identically conserved in plasmin,
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HGF and prothrombin, except for F instead of Y in pro-
thrombin (20) . Our finding of this motif in the BU-11 and
BU-12 fragments of theMSP ot chain strongly suggests that
there are kringles in the ot chain, and provides added evi-
dence for the relationship ofMSP to this protein group. Since
kringles are thought to mediate binding of plasmin to lysine
on its target molecule, it will be of interest to determine if
epsilon amino acid caproic acid (which inhibits binding of
kringles to lysine residues [21]) inhibits MSP binding or bio-
logical activity.
The possible structural relationship ofMSP to coagulation-
fibrinolysis proteins suggests a mechanism for regulation of
the potent activity of MSP, which is present in all normal
mammalian plasma or serum . In analogy to prothrombin and
plasminogen, MSP in circulating blood could be in the form
of a single chain inactive precursor. When blood is shed, MSP
could be cleaved by a proteolytic enzyme of the clotting cas-
cade to form the disulfide-linked ot-/3 chain active complex .
In the intact organism, the source of an activating proteo-
lyticenzyme could be the extrinsic coagulation pathway. For
example, LPS causes macrophages to elaborate a procoagulant
(22), which initiates activation of clotting cascade proteo-
lytic enzymes.
We have shown that MSP activates mouse resident perito-
neal macrophages to ingestbound EIgMC3b . This observa-
tion links MSP to an important body of literature on the
activation of the C3b receptor (CR1) of peritoneal macro-
phages and cultured human blood monocytes (13-17, 23-25) .
The possible significance of CR1 activation has been out-
lined in an interesting discussion by Griffin and Griffin (13) ;
it includes host defense against microbial pathogens, cellular
injury in immune complex disease, and destruction of neo-
plastic cells .
At this early stage in our knowledge, the biological role
ofMSP relates to the direct or indirect activation of two dis-
tinct receptors, CR1 and the C5a receptor. In both cases,
ligation ofthe receptor leads to a cellular response (phagocy-
tosis or chemotaxis) if an additional stimulus is provided by
addition ofMSP. It is not necessary to add MSP before liga-
tion of CR1 . EIgMC3b that are bound to macrophage
monolayers in the absence ofMSP are rapidly ingested when
MSP is added (our unpublished observations) . It is likely that
MSP affects a specific step in the stimulus-response pathway
of ligated CR1 or C5a receptors. Since activation of CR1
by PMA is associated with phosphorylation ofCR1, it will
be of interest to determine ifCR1 or C5a receptors are phos-
phorylated after activation by MSP.
We reported that stimulation of resident macrophages to
become responsive toC5a could be achieved not only by low
concentrations ofMSP, but also by relatively high concen-
trations (1-10 mg/ml) of serum albumin (26). The effective-
ness of albumin depended on the method ofpurification, sug-
gesting that albumin may be a carrier for an activating
stimulus . When chemotactic responses of resident macro-
phages were compared with those of inflammatory exudate
peritoneal macrophages (induced by thioglycollate or serum),
we found that resident macrophages could be stimulated by
eitherMSP or albumin, but exudate macrophages were respon-sive only to albumin . Thus, MSP responsiveness is a marker
for the resident macrophage. It does not occur in either mouse
exudate macrophages (26) or in freshly isolated and washed
human blood monocytes (our unpublished observations), both
of which represent an earlier stage of mononuclear phago-
cyte development . These observations suggest that MSP re-
sponsiveness may be associated with a receptor that appears
when monocytes become mature tissue macrophages. Like-
wise, Wright et al . (15) reported that fibronectin-mediated
activation of human monocyte C3b receptors was observed
only after at least 3 d in tissue culture. IfMSP activates human
monocyteC3b receptors and the effect depends on the matura-
tional stage of the cells, binding studies with labeled MSP
could determine whether MSP-responsiveness is due to ap-
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pearance ofa receptor or to a post-receptor event. We expect
that MSP-responsive cells have a high affinity MSP receptor,
in view of the low concentration of MSP [10-1° M] that
elicits biological activity (Figs . 5 and 6) .
We can now also begin investigations to determine the
in vivo significance ofMSP. Does it affect resident popula-
tions of the monocyte lineage - such as tissue macrophages,
lung macrophages, Kupffer cells or osteoclasts? Does it play
a role in granuloma formation? In view of its presence in
circulating blood, is it made by hepatic cells, and could it
be an acute phase protein? We are developing MSP-specific
probes suitable for ELISA ofMSP in plasma and for immuno-
histochemical localization of MSP to determine its cellular
source and sites of action.
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